敌手 发表于 2025-3-27 00:04:55
Epigenetic Markers of Ovarian Cancer; however, although the majority of patients are initially responsive to chemotherapy, most of them eventually develop drug-resistant disease, that is essentially incurable. A better understanding of the molecular pathogenesis underlying ovarian cancer is the key to identifying markers for early detection and novel therapeutics.Palpable 发表于 2025-3-27 04:09:49
http://reply.papertrans.cn/71/7052/705194/705194_32.png小隔间 发表于 2025-3-27 06:17:54
http://reply.papertrans.cn/71/7052/705194/705194_33.png乳白光 发表于 2025-3-27 12:13:33
Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting thll need to become individualized. Specifically targeted drugs continue to receive FDA approval and guide treatment selection on the basis of the underlying dysfunctional genetic, transcriptional, or protein regulation driving their tumor progression.TERRA 发表于 2025-3-27 13:38:29
http://reply.papertrans.cn/71/7052/705194/705194_35.pngtenosynovitis 发表于 2025-3-27 18:59:39
http://reply.papertrans.cn/71/7052/705194/705194_36.png荣幸 发表于 2025-3-27 23:57:13
George Coukos,Andrew Berchuck,Robert OzolsMeeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances iABOUT 发表于 2025-3-28 04:48:31
http://reply.papertrans.cn/71/7052/705194/705194_38.pngAV-node 发表于 2025-3-28 07:44:31
https://doi.org/10.1007/978-0-387-68969-2B7 family members; BRCA; Carcinom; Epigenetic markers; Ovarian Cancer; Ovulatory factor; Pathogenesis; Reguelastic 发表于 2025-3-28 10:44:04
Mandi M. Murph,Debra L. Smith,Bryan Hennessy,Yiling Lu,Corwin Joy,Kevin R. Coombes,Gordon B. Millsormation toward understanding the nature and mechanism of the underlying disorders..The book represents a unique mixture of textbook and atlas, always combining concise statements in English, German, and Spanish on one page with didactically conceived explanatory illustrations on the facing page. ..978-3-642-44085-4978-3-540-30061-8